The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Liver Pathology and the Metabolic Syndrome X in Severe Obesity
Open accessAbstract
The metabolic syndrome X, characterized by insulin resistance, dyslipidemia, hypertension, and a male, visceral distribution of adipose tissue, is associated with increased morbidity and mortality from several prevalent diseases, such as diabetes, cancers, myocardial infarction, and stroke. Because the liver has a central role in carbohydrate, lipid, and steroid metabolism, we investigated the relationships between liver pathology and the metabolic syndrome. Blood chemistry, anthropometry (waist/hip circumference ratio), and intraoperative routine knife biopsies of the liver were obtained in 551 (112 men) severely obese patients (body mass index, 47 +/- 9; mean +/- SD) undergoing antiobesity surgery. Steatosis was found in 86%, fibrosis in 74%, mild inflammation or steatohepatitis in 24%, and unexpected cirrhosis in 2% (n = 11) of the patients. The risk of steatosis was 2.6 times greater in men than in women (P < 0.0001). With each addition of 1 of the 4 components of the metabolic syndrome, elevated waist/hip ratio, impaired glucose tolerance, hypertension, and dyslipidemia, the risk of steatosis increased exponentially from 1- to 99-fold (P < 0.001). Fibrosis correlated with steatosis (r = 0.56; P < 0.0001), whereas patients with diabetes or impaired glucose tolerance had a 7-fold increased risk of fibrosis (P < 0.0001). Diabetes, steatosis, and age were all significant indicators of cirrhosis, whereas inflammation was only associated with age. We conclude that the metabolic syndrome via impaired glucose tolerance is strongly correlated with steatosis, fibrosis, and cirrhosis of the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Pories, W. J., Swanson, M. S., MacDonald, K. G., Long, S. B., Morris, P. G., Brown, B. M., Barakat, H. A., deRamon, R. A., Israel, G., Dolezal, J. M., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00011 · Cited by 2,293
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Regional adiposity and morbidity.
Kissebah, A. H., & Krakower, G. R. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.761 · Cited by 1,130
"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.
Björntorp, P. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.493 · Cited by 1,127
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Lipid peroxidation and cellular damage in toxic liver injury.
Comporti, M. (1985) · PubMed · Cited by 539
Nibbling versus gorging: metabolic advantages of increased meal frequency
Jenkins, D. J. A., Wolever, T. M. S., Vuksan, V., Brighenti, F., Cunnane, S. C., Rao, A. V., Jenkins, A. L., Buckley, G., Patten, R., Singer, W., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910053211403 · Cited by 467
Biliopancreatic diversion for obesity at eighteen years
Scopinaro, N., Gianetta, E., Adami, G. F., Friedman, D., Traverso, E., Marinari, G. M., Cuneo, S., Vitale, B., Ballari, F., Colombini, M., et al. (1996) · Surgery · doi:10.1016/s0039-6060(96)80111-5 · Cited by 390
Hebert, L. F., Daniels, M. C., Zhou, J., Crook, E. D., Turner, R. L., Simmons, S. T., Neidigh, J. L., Zhu, J. S., Baron, A. D., & McClain, D. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118876 · Cited by 335
Abdominal obesity and the development of noninsulin‐dependent diabetes mellitus
Björntorp, P. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040607 · Cited by 294
Cytokines and Alcoholic Liver Disease
McClain, C., Hill, D., Schmidt, J., & Diehl, A. (1993) · Seminars in Liver Disease · doi:10.1055/s-2007-1007347 · Cited by 279
Banerji, M. A., Buckley, M.-C., Chaiken, R. L., Gordon, D., Lebovitz, H. E., & Kral, J. G. (1995) · PubMed · Cited by 180
Gender-dependent alterations in serum leptin in alcoholic cirrhosis
McCullough, A. J., Bugianesi, E., Marchesini, G., & Kalhan, S. C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70267-7 · Cited by 154
Goto, T., Onuma, T., Takebe, K., & Kral, J. G. (1995) · PubMed · Cited by 145
Teff, K. L., & Engelman, K. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.270.6.r1371 · Cited by 128
Leptin, obesity, and liver disease
Kaplan, L. M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70272-0 · Cited by 122
Fatty acids in the portal vein of the rat regulate hepatic insulin clearance.
Svedberg, J., Strömblad, G., Wirth, A. G., Smith, U., & Björntorp, P. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115534 · Cited by 121
Relationship between 505 paired liver tests and biopsies in 242 obese patients
Galambos, J. T., & Wills, C. E., Jr. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90691-1 · Cited by 105
Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics.
Hennes, M. M. I., Shrago, E., & Kissebah, A. H. (1990) · PubMed · Cited by 89
Nonalcoholic steatohepatitis: An expanded clinical entity
Farahvash, M. J. (1993) · Hepatology · doi:10.1016/0270-9139(93)92222-l · Cited by 89
Relationship between impaired glucose tolerance, non‐insulin‐dependent diabetes mellitus and obesity
Ferrannini, & Camastra, S. (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.0280s2003.x · Cited by 68
Hepatic lipid metabolism in severe human obesity
Kral, J. G., Lundholm, K., Björntorp, P. A., Sjöström, L., & Scherstén, T. (1977) · Metabolism · doi:10.1016/0026-0495(77)90020-8 · Cited by 67
Phillips, W. T., Schwartz, J. G., & McMahan, C. A. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01296773 · Cited by 47
Treatment of obesity-induced steatohepatitis with vitamin E
Lavine, J. E. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)85214-1 · Cited by 15
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Simental-Mendía, L. E., Rodríguez-Morán, M., & Guerrero-Romero, F. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0034 · Cited by 2,445
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Metadata
- Authors
- Marceau, P.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-05-01
- Volume
- 84
- Issue
- 5
- Pages
- 1513-1517
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2033630237
- Cited by
- 635
- References
- 28
- FWCI
- 19.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.